15392-98-0

Basic information

• Product Name: (4aR,6R,7R,7aR)-6-(6-amino-9H-purin-9-yl)-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate
• CAS NO: 15392-98-0
• Molecular Formula: C₁₄H₁₈N₅O₇P
• Molecular Weight: 399.2958
• Mol File: 15392-98-0.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 651.4°C at 760 mmHg
• Flash Point: 347.7°C
• Density: 1.96g/cm³
• Vapor Pressure: 7.41E-18mmHg at 25°C
• Refractive Index: 1.799
• CAS DataBase Reference: (4aR,6R,7R,7aR)-6-(6-amino-9H-purin-9-yl)-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (4aR,6R,7R,7aR)-6-(6-amino-9H-purin-9-yl)-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate(15392-98-0)
• EPA Substance Registry System: (4aR,6R,7R,7aR)-6-(6-amino-9H-purin-9-yl)-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate(15392-98-0)

Safety Data

• Hazardous Substances Data: 15392-98-0(Hazardous Substances Data)

Usage

General Description

The chemical compound "(4aR,6R,7R,7aR)-6-(6-amino-9H-purin-9-yl)-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate" is a complex molecule with a tetrahydropyran ring and a purine base. It contains a butanoate group and a phosphate group, adding to its structural complexity. The purine base suggests a potential role in nucleic acid synthesis or metabolism, while the phosphate group can play a role in energy transfer or as a structural component in biomolecules. The presence of the butanoate group indicates a potential role in lipid metabolism or signaling. The compound's unique structure and combination of functional groups suggest potential biological activity and may hold promise for pharmaceutical or biochemical applications.

Upstream product

• 106-31-0 butanoic acid anhydride 
• 60-92-4 cAMP 

Relevant articles and documents

only child acid radical link phosphorus adenosine or its salt preparation method and application

The invention discloses a preparation method and application of monobutyryl adenosine cyclophosphate or salt thereof. The preparation method comprises the following steps: in the preparation process of the monobutyryl adenosine cyclophosphate disclosed as Formula I, carrying out acylation reaction on adenosine cyclophosphate and n-butyric acid anhydride in an aprotic solvent in a gas protective atmosphere under dark conditions by using an organic alkali as a catalyst, mixing the acylation reaction solution with water, and carrying out hydrolysis reaction; and in the preparation process of the monobutyryl adenosine cyclophosphate salt disclosed as Formula I, after preparing the monobutyryl adenosine cyclophosphate disclosed as Formula I in a polar organic solvent, reacting with alkali metal salt or alkali earth metal salt. The invention also discloses application of the monobutyryl adenosine cyclophosphate or salt thereof in drug quality control of dibutyryl adenosine cyclophosphate or salt thereof. The preparation method is simple to operate, can obtain the high-purity monobutyryl adenosine cyclophosphate or salt thereof, and can control the quality of the dibutyryl adenosine cyclophosphate drug.